Medicare/Medicaid issues, diabetes self-management training, safe harbor rebate reform, diabetic retinopathy issues, all issues pertaining to people with diabetes.
diabetes self-management training, diabetic retinopathy, safe harbor rebate reform, national mail order pharmacy issues, all issues pertaining to people with diabetes.
Special Diabetes Program and Special Diabetes Program for Indians, any issue pertaining to people with diabetes.
Duration: April 1, 2016
to
September 19, 2019
General Issues: Health Issues , Medicare/Medicaid , Budget/Appropriations , Pharmacy , Insurance
Spending: about $0 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2016: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Central Intelligence Agency (CIA), Food & Drug Administration (FDA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
3rd Quarter, 2019
Diabetes Patient Advocacy Coalition in-house lobbying effort was terminated on Oct. 17, 2019
Original Filing: 301067887.xml
Lobbying Issues
Medicare/Medicaid issues, diabetes self-management training, safe harbor rebate reform, diabetic retinopathy issues, all issues pertaining to people with diabetes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
diabetes self-management training, diabetic retinopathy, safe harbor rebate reform, national mail order pharmacy issues, all issues pertaining to people with diabetes.
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) U.S. Senate U.S. House of Representatives
Lobbying Issues
Special Diabetes Program and Special Diabetes Program for Indians, any issue pertaining to people with diabetes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2019
In Q2, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on Aug. 14, 2019.
Original Filing: 301061041.xml
Lobbying Issues
Medicare/Medicaid issues, diabetes self-management training, safe harbor rebate reform, diabetic retinopathy issues, all issues pertaining to people with diabetes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
diabetes self-management training, diabetic retinopathy, safe harbor rebate reform, national mail order pharmacy issues, all issues pertaining to people with diabetes.
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) U.S. Senate U.S. House of Representatives
Lobbying Issues
Special Diabetes Program and Special Diabetes Program for Indians, any issue pertaining to people with diabetes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
Diabetes Patient Advocacy Coalition amended a lobbying report for in-house lobbying in Q12019 on June 20, 2019
Original Filing: 301042279.xml
Lobbying Issues
Medicare/Medicaid issues, diabetes self-management training, safe harbor rebate reform, diabetic retinopathy issues, all issues pertaining to people with diabetes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
diabetes self-management training, diabetic retinopathy, safe harbor rebate reform, national mail order pharmacy issues, all issues pertaining to people with diabetes.
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) U.S. Senate U.S. House of Representatives
Lobbying Issues
Special Diabetes Program and Special Diabetes Program for Indians, any issue pertaining to people with diabetes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on April 16, 2019.
Original Filing: 301026456.xml
Lobbying Issues
Medicare/Medicaid issues, diabetes self-management training, safe harbor rebate reform, diabetic retinopathy issues, all issues pertaining to people with diabetes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
diabetes self-management training, diabetic retinopathy, safe harbor rebate reform, national mail order pharmacy issues, all issues pertaining to people with diabetes.
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) U.S. Senate U.S. House of Representatives
Lobbying Issues
Special Diabetes Program and Special Diabetes Program for Indians, any issue pertaining to people with diabetes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
In Q4, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on Jan. 14, 2019.
Original Filing: 301004421.xml
Lobbying Issues
CMS/HHS to suspend CBP for diabetes testing supplies
CMS/HHS to allow smart devices to be used with CGM systems for Medicare
Funding for Diabetes Prevention Programs
DSMT for Medicare
Diabetes Vision Loss
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
CMS/HHS to suspend CBP for diabetes testing supplies
CMS/HHS to provide funding for DPP
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2018
In Q3, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on Nov. 6, 2018.
Original Filing: 301000126.xml
Lobbying Issues
CMS/HHS to suspend CBP for diabetes testing supplies
CMS/HHS to allow smart devices to be used with CGM systems for Medicare
Funding for Diabetes Prevention Programs
DSMT for Medicare
Diabetes Vision Loss
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
CMS/HHS to suspend CBP for diabetes testing supplies
CMS/HHS to provide funding for DPP
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2018
In Q2, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on Aug. 21, 2018.
Original Filing: 300981059.xml
Lobbying Issues
CMS/HHS to suspend CBP for diabetes testing supplies
CMS/HHS to allow smart devices to be used with CGM systems for Medicare
Funding for CHIP
Funding for Special Diabetes Program Type 1
Funding for Diabetes Prevention Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
CMS/HHS to suspend CBP for diabetes testing supplies
CMS to allow smart devices to be used for viewing CGM data for Medicare
CMS/HHS to provide funding for DPP
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) U.S. Senate U.S. House of Representatives
Lobbying Issues
CHIP reauthorization
SDP reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2018
In Q1, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on April 12, 2018.
Original Filing: 300943945.xml
Lobbying Issues
H.R. 3271 Protecting Access to Diabetes Supplies Act of 2017.
S. 1914 Protecting Access to Diabetes Supplies Act of 2017.
CMS/HHS to suspend CBP for diabetes testing supplies
CMS/HHS to allow smart devices to be used with CGM systems for Medicare
Funding for CHIP
Funding for Special Diabetes Program Type 1
Funding for Diabetes Prevention Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
CMS/HHS to suspend CBP for diabetes testing supplies
CMS to allow smart devices to be used for viewing CGM data for Medicare
CMS/HHS to provide funding for DPP
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) U.S. Senate U.S. House of Representatives
Lobbying Issues
CHIP reauthorization
SDP reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2017
In Q4, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on Jan. 15, 2018.
Original Filing: 300923801.xml
Lobbying Issues
H.R. 1628,American Healthcare Act of 2017,
H.R. 3271 Protecting Access to Diabetes Supplies Act of 2017.
S. 1914 Protecting Access to Diabetes Supplies Act of 2017.
CMS/HHS to suspend CBP for diabetes testing supplies
CMS/HHS to allow smart devices to be used with CGM systems for Medicare
Funding for CHIP
Funding for Special Diabetes Program Type 1
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
CMS/HHS to suspend CBP for diabetes testing supplies
CMS to allow smart devices to be used for viewing CGM data for Medicare
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) U.S. Senate U.S. House of Representatives
Lobbying Issues
CHIP reauthorization
SDP reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2017
In Q3, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on Oct. 4, 2017.
Original Filing: 300901433.xml
Lobbying Issues
H.R. 1628,American Healthcare Act of 2017,
H.R. 3271 Protecting Access to Diabetes Supplies Act of 2017.
CMS/HHS to suspend CBP for diabetes testing supplies
Agencies Lobbied
U.S. Senate U.S. House of Representatives Central Intelligence Agency (CIA) Health & Human Services - Dept of (HHS)
Lobbying Issues
CMS/HHS to suspend CBP for diabetes testing supplies
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2017
In Q2, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on July 10, 2017.
Original Filing: 300883109.xml
Lobbying Issues
H.R. 1628 American Health Care Act of 2017, H.R. 1628, Better Care Reconciliation Act of 2017,
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2017
In Q1, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on April 6, 2017.
Original Filing: 300862837.xml
Lobbying Issues
H.R. 1628 American Health Care Act of 2017
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
In Q4, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on Dec. 26, 2016.
Original Filing: 300843161.xml
Lobbying Issues
S.804/HR.1427 MEDICARE CGM ACCESS ACT OF 2015, S.586/HR1192 NDCCA, S.1345/HR 1726 ACCESS TO QUALITY DIABETES EDUCATION ACT, S.1131/HR2102 MEDICARE NDPP, HR 771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, MEDICARE COMPETITIVE BIDDING PROGRAM,
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
3rd Quarter, 2016
Diabetes Patient Advocacy Coalition amended a lobbying report for in-house lobbying in Q32016 on Oct. 12, 2016
Original Filing: 300826974.xml
Lobbying Issues
S.804/HR.1427 MEDICARE CGM ACCESS ACT OF 2015, S.586/HR1192 NDCCA, S.1345/HR 1726 ACCESS TO QUALITY DIABETES EDUCATION ACT, S.1131/HR2102 MEDICARE NDPP, HR 771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, MEDICARE COMPETITIVE BIDDING PROGRAM, Docket No. FDA-2016-N-0400 FDA LANCET DEVICES GUIDANCE DOCKET, Docket No. FDA-2016-N-0001 FDA DIABETES DEXCOM G5 LABELING CHANGE
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
3rd Quarter, 2016
In Q3, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on Oct. 11, 2016.
Original Filing: 300826541.xml
Lobbying Issues
S.804/HR.1427 MEDICARE CGM ACCESS ACT OF 2015, S.586/HR1192 NDCCA, S.1345/HR 1726 ACCESS TO QUALITY DIABETES EDUCATION ACT, S.1131/HR2102 MEDICARE NDPP, HR 771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, MEDICARE COMPETITIVE BIDDING PROGRAM, Docket No. FDA-2016-N-0400 FDA LANCET DEVICES GUIDANCE DOCKET, Docket No. FDA-2016-N-0001 FDA DIABETES DEXCOM G5 LABELING CHANGE
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
2nd Quarter, 2016
Diabetes Patient Advocacy Coalition filed a lobbying registration on July 13, 2016 for in-house lobbying efforts, effective April 1, 2016.
Original Filing: 300809135.xml
Issue(s) they said they’d lobby about: S.804/HR.1427 - MEDICARE CGM ACCESS ACT OF 2015, S.586/HR.1192 - NDCCA, S.1345/HR 1726 ACCESS TO DIABETES QUALITY EDUCATION ACT, S.1131/HR.2102 MEDICARE NDPP, HR.771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, SPECIAL DIABETES FUNDING PROGRAM, CMS COMPETITIVE BIDDING PROGRAMS FOR DIABETES SUPPLIES, RESTRICTION OF ACCESS TO DIABETES TREATMENTS BY INSURANCE PROVIDERS .
2nd Quarter, 2016
Diabetes Patient Advocacy Coalition amended a lobbying report for in-house lobbying in Q22016 on July 13, 2016
Original Filing: 300809247.xml
Lobbying Issues
S.804/HR.1427 MEDICARE CGM ACCESS ACT OF 2015, S.586/HR1192 NDCCA, S.1345/HR 1726 ACCESS TO QUALITY DIABETES EDUCATION ACT, S.1131/HR2102 MEDICARE NDPP, HR 771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, MEDICARE COMPETITIVE BIDDING PROGRAM, Docket No. FDA-2016-N-0400 FDA LANCET DEVICES GUIDANCE DOCKET, Docket No. FDA-2016-N-0001 FDA DIABETES DEXCOM G5 LABELING CHANGE
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
2nd Quarter, 2016
In Q2, Diabetes Patient Advocacy Coalition had in-house lobbyists. The report was filed on July 13, 2016.
Original Filing: 300809156.xml
Lobbying Issues
S.804/HR.1427 MEDICARE CGM ACCESS ACT OF 2015, S.586/HR1192 NDCCA, S.1345/HR 1726 ACCESS TO QUALITY DIABETES EDUCATION ACT, S.1131/HR2102 MEDICARE NDPP, HR 771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, MEDICARE COMPETITIVE BIDDING PROGRAM, Docket No. FDA-2016-N-0400 FDA LANCET DEVICES GUIDANCE DOCKET, Docket No. FDA-2016-N-0001 FDA DIABETES DEXCOM G5 LABELING CHANGE
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate